Data use:

We use cookies and similar tools to make your use of this website easy and to keep it working properly. We may share data about you and how you use the site with third parties, such as analytics and marketing partners. Learn more in our Privacy Policy and Terms of Use. By continuing to use the site, you agree to this.

Site Logo

for Business

Myrbetriq^® (mirabegron) – First-time generic launch halted

April 23, 2024 - The Federal Circuit court issued a temporary injunction halting Lupin and Zydus launch of AB-rated generic versions of Astellas’ Myrbetriq (mirabegron) 25 mg extended-release tablets.

Download PDF

RxNews®

Myrbetriq® (mirabegron) – First-time generic launch halted

Myrbetriq^® (mirabegron) – First-time generic launch halted